In the presence of somatostatin-14 or some of its receptorial agonists, the uptake of large neutral amino acids by isolated brain microvessels was found to be inhibited up to 50%, no other transport system being affected. Although the luminal and abluminal sides of brain endothelial cells are both capable of taking up large neutral amino acids, only uptake from the abluminal side appears to be inhibited by somatostatin. The involvement of a type-2 somatostatin receptor was suggested by assays with a series of receptor-specific somatostatin agonists, and was confirmed by the release of inhibition caused by a specific type-2 receptor antagonist. A type-2-specific mRNA was indeed shown to be present in both bovine brain microvessels ex vivo and primary cultures of endothelial cells from rat brain microvessels.
Inhibitory effect of somatostatin on neutral amino acid transport in isolated brain microvessels / Cardelli, Patrizia; Fiori, Anna; Corleto, Vito Domenico; Savi, M. R.; Granata, F.; Ceci, Fabrizio; Ferraguti, Giampiero; Potenza, R. L.; DELLE FAVE, Gianfranco; Jensen, R. T.; Strom, Roberto. - In: JOURNAL OF NEUROCHEMISTRY. - ISSN 0022-3042. - STAMPA. - 78:2(2001), pp. 349-357. [10.1046/j.1471-4159.2001.00412.x]
Inhibitory effect of somatostatin on neutral amino acid transport in isolated brain microvessels.
CARDELLI, Patrizia;FIORI, Anna;CORLETO, Vito Domenico;CECI, Fabrizio;FERRAGUTI, Giampiero;DELLE FAVE, Gianfranco;STROM, Roberto
2001
Abstract
In the presence of somatostatin-14 or some of its receptorial agonists, the uptake of large neutral amino acids by isolated brain microvessels was found to be inhibited up to 50%, no other transport system being affected. Although the luminal and abluminal sides of brain endothelial cells are both capable of taking up large neutral amino acids, only uptake from the abluminal side appears to be inhibited by somatostatin. The involvement of a type-2 somatostatin receptor was suggested by assays with a series of receptor-specific somatostatin agonists, and was confirmed by the release of inhibition caused by a specific type-2 receptor antagonist. A type-2-specific mRNA was indeed shown to be present in both bovine brain microvessels ex vivo and primary cultures of endothelial cells from rat brain microvessels.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.